While everyones journey on semaglutide or tirzepatide (GLP-1s) is different, there are enough commonalities to come up with a typical patients experience with these medications
Energy and Motivation May Fluctuate Some patients report: Increased fatigue Irritability Mental distraction Decreased enthusiasm for routine habits These symptoms often relate to changes in appetite hormones and blood sugar stability
How quickly you lost weight: Slow and steady weight loss gives your skin time to adjust naturally
This needle size is supported by clinical evidence and is widely recommended for subcutaneous injections, offering an optimal balance of comfort, safety, and effective medication delivery for the vast majority of patients
Tirzepatide is administered as a once-weekly subcutaneous injection, starting at 2.5 mg for the first 4 weeks as an initiation dose only
Thyroid cancer Wegovy has been linked to thyroid tumours in some animal studies